Richard Barry insider trades
Open-market stock purchases and sales by Richard Barry, Unknown at Sarepta Therapeutics, Inc, from SEC Form 4 filings since Dec 12, 2012.
Track record: 18% of 17 scored buys are up 5% or more since purchase, averaging -51%.